动脉灌注化疗及栓塞治疗原发性肝癌.doc

动脉灌注化疗及栓塞治疗原发性肝癌.doc动脉灌注化疗及栓塞治疗原发性肝癌
动脉灌注化疗及栓塞治疗原发性肝癌
文章来源:肿瘤防治杂志 2000年第2期第17卷文章作者:尹强黄英昌王丰松丁兆军发表时间:2004-07-31 21:01:00
关键字:原发性肝癌;动脉灌注;栓塞治疗;化疗药物
【摘要】目的:观察动脉灌注化疗及栓塞治疗原发性肝癌的疗效。方法:采用肝动脉插管灌注化疗及栓塞治疗106例病人,4~6周1次,共进行463次,最多6次,最少2次。结果:CR+%,1、2、%、%、%。结论:采用动脉灌注化疗及栓塞术,对拒绝手术或失去手术机会的原发性肝癌患者是一种有效的治疗方法。
中图分类号:R7357; 文献标识码:B 文章编号:1009-4571(2000)02-0160-02
Transcatheter arterial infusion chemoembolization in the treatment of primary liver cancer
YIN Qiang,HUANG Ying-chang,WANG Feng-song,et al.
(People’s Hospitol of Rizhao,Shandong Province,Rizhao 276800)
【Abstract】Objective:The theraputic effect of transcatheter arterial infusion chemoembolization(TACE)to Primary liver :TACE was given to the patients once every 4-6 weeks,106 patients recEived 463 times TACE,the most 6 times,the least 2 :CR+PR accounted for %.1-,2-,3-year survival rate were %,%,%,:To the patients of primary liver cancer who rejected operation and the patients who had lost the chance of operation,TACE would be an effective way of treatment.
【Key words】primary liver cancer;transcatheter arterial chemotherapy;transcatheter arterial embolization;chemotherapy drug
1992~1996年我院共行肝动脉插管灌注化疗栓塞术(TACE)治疗原发性肝癌132例,失访26例,其中资料较完整的共106例,取得了较好的疗效,报告如下。
1 临床资料
一般资料
病人为同期住院或门诊病人。所有病例均经临床、AFP、肝酶谱、B超、CT、MRI、肝动脉造影或病理检查确诊。106例病人中,男65例,女41例,年龄2